Home › Funds › Checkpoint Capital L.P. › RVMD

Checkpoint Capital L.P. position in RVMD

REVOLUTION MEDICINES INC · Health Care

Checkpoint Capital L.P. reported holding 422,911 shares of RVMD (REVOLUTION MEDICINES INC) in its Q3 2026 13F filing — a position valued at US$86.8M, representing 19.62% of its reported portfolio and ranking #3 among its reported holdings. Checkpoint Capital L.P. has disclosed RVMD holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)422.91K sh
Reported value held$86.81M
Portfolio Weight19.62%
First reportedQ4 2024
Last changeAdd
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Checkpoint Capital L.P.'s RVMD position evolved

Checkpoint Capital L.P. first disclosed a stake in RVMD in Q4 2024 at 210,000 shares (US$9.2M). The position peaked in Q3 2026 at 422,911 shares, worth US$86.8M. Across 8 filings, Checkpoint Capital L.P. increased the stake 4 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 422,911 shares valued at US$86.8M — an increase of 12,558 shares quarter over quarter.. Notable position changes include a 87% increase in Q1 2025 (shares rose 4% over the following quarter), a 76% increase in Q3 2025 (shares rose 71% over the following quarter), a 56% increase in Q2 2026 (shares rose 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 210.00K $9.19M New
Q1 2025 392.01K $13.86M Add
Q2 2025 280.00K $10.30M Reduce
Q3 2025 492.30K $22.99M Add
Q4 2025 370.00K $29.47M Reduce
Q1 2026 262.54K $25.53M Reduce
Q2 2026 410.35K $76.85M Add
Q3 2026 422.91K $86.81M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RVMD and 13F data

RVMD (REVOLUTION MEDICINES INC) is a Health Care company. 58 other funds we track also report a position in RVMD — the largest reported positions include Farallon Capital Management (US$2.54B), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$2.54B), BAKER BROS. ADVISORS LP (US$2.14B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RVMD

All RVMD fund holders →

FAQ

How long has Checkpoint Capital L.P. held RVMD?

Checkpoint Capital L.P. has disclosed RVMD holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is Checkpoint Capital L.P.'s current position in RVMD?

As of Q3 2026, Checkpoint Capital L.P. holds 422.91K shares of RVMD (REVOLUTION MEDICINES INC), valued at $86.81M, representing 19.62% of its reported portfolio and ranking #3.

Has Checkpoint Capital L.P. been buying or selling RVMD?

In the latest 13F filing (Q3 2026), Checkpoint Capital L.P. increased its position in RVMD. The position peaked in Q3 2026 at 422.91K shares.

Which other funds hold RVMD?

Other major institutional holders of RVMD include Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., BAKER BROS. ADVISORS LP, among 58 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.